BALTIMORE (AP) — The University of Maryland School of Medicine’s Institute of Human Virology will receive $23.4 million from a consortium of funding sources to pay for preclinical development of an HIV/AIDS vaccine candidate.
Gov. Martin O’Malley and Dr. Robert Gallo, who founded the Institute of Human Virology at the university, made the announcement Thursday in Baltimore.
The grants include $16.8 million from the Bill & Melinda Gates Foundation.
The U.S. Army’s Military HIV Research Program is contributing $2.2 million. Other research funding is coming from a variety of sources, including the U.S. National Institutes of Health.
The vaccine candidate immunogen is designed to elicit strongly protective antibody responses across the spectrum of HIV-1 strains.
(Copyright 2011 by The Associated Press. All Rights Reserved.)